Prazosin hydrochloride
Cat. No.：YN321416
| 产品名称: | Prazosin hydrochloride |
| CAS No.: | 19237-84-4 |
| Chemical Name: | [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-methanone, monohydrochloride |
| Synonyms: | 盐酸哌唑嗪 |
| 分子量: | 419.86 |
| 分子式: | C₁₉H₂₂ClN₅O₄ |
| SMILES: | O=C(N1CCN(C2=NC(N)=C3C=C(OC)C(OC)=CC3=N2)CC1)C4=CC=CO4.Cl |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Prazosin 盐酸盐是 α 肾上腺素阻断剂，可作用于高血压、焦虑和恐慌症等。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Nagatomo, T., Tsuchihashi, H., Sasaki, S., et al.Displacement by α-adrenergic agonists and antagonists of 3H-prazosin bound to the α-adrenoceptors of the dog aorta and the rat brainJapan J. Pharmacol.37(2),181-187(1985)
Kristek, F., and Koprdova, R.Long-term effect of prazosin administration on blood pressure, heart and structure of coronary artery of young spontaneously hypertensive ratsJ. Physiol. Pharmacol.62(3),295-301(2011)
Leiker, A.J., DeGraff, W., Choudhuri, R., et al.Radiation enhancement of head and neck squamous cell carcinoma by the dual PI3K/mTOR inhibitor PF-05212384Clin. Cancer Res.21(12),2792-2801(2015)
Bylund, D.B., and Ray-Prenger, C.Alpha-2A and alpha-2B adrenergic receptor subtypes: Attenuation of cyclic AMP production in cell lines containing only one receptor subtypeJ. Pharmacol. Exp. Ther.251(2),640-644(1989)
Paul, P., Lahaye, C., Delagrange, P., et al.Characterization of 2-[125]iodomelatonin binding sites in Syrian hamster peripheral organsJ. Pharmacol. Exp. Ther.290(1),334-340(1999)
Fernandes, M., Smith, I.S., Weder, A., et al.Prazosin in the treatment of hypertensionClin. Sci. Mol. Med. Suppl.48,181s-184s(1975)
Verplaetse, T.L., Rasmussen, D.D., Froehlich, J.C., et al.Effects of prazosin, an α1-adrenergic receptor antagonist, on the seeking and intake of alcohol and sucrose in alcohol-preferring (P) ratsAlcohol Clin. Exp. Res.36(5),881-886(2012)
Skelly, M.J., and Weiner, J.L.Chronic treatment with prazosin or duloxetine lessens concurrent anxiety-like behavior and alcohol intake: Evidence of disrupted noradrenergic signaling in anxiety-related alcohol useBrain Behav.4(4),468-483(2014)
